CytoDyn Inc. Completes $14.5 Million Private Equity Offering

CytoDyn Inc. , a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced the completion of its equity capital raise for a total of $14.5 million through a private offering.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131024006889&newsLang=en&ndmConfigId=1000639&vnsId=41